Provided by Tiger Trade Technology Pte. Ltd.

CERo Therapeutics Holdings, Inc.

0.0068
0.0000
Volume:1.00
Turnover:0.01
Market Cap:- -
PE:- -
High:0.0068
Open:0.0068
Low:0.0068
Close:0.0068
52wk High:0.0623
52wk Low:0.0037
Shares:- -
Float Shares:- -
Volume Ratio:0.00
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:-210.22%
PB:0.00
PE(LYR):- -

Loading ...

Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 03, 2024

Correspondence

Form CORRESP - Correspondence
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
Jun 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 05, 2024

Correspondence

Form CORRESP - Correspondence
Jun 05, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 03, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

Correspondence

Form CORRESP - Correspondence
Apr 27, 2024

Correspondence

Form CORRESP - Correspondence
Apr 27, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 02, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 02, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report